Fludarabine-Based Reduced Intensity Conditioning for Stem Cell Transplantation of Fanconi Anemia Patients from Fully Matched Related and Unrelated Donors

Biology of Blood and Marrow Transplantation

Volumn 12, Issue 7, 2006, Pages 712-718

  Bitan, M ^a   Or, R ^a   Shapira, M Y ^a   Aker, M ^a   Resnick, I B ^a   Ackerstein, A ^a   Samuel, S ^a   Elad, S ^a   Slavin, S ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Fanconi anemia; Fludarabine; Reduced intensity conditioning; Stem cell transplantation

Indexed keywords

ACICLOVIR; ALEMTUZUMAB; ALLOPURINOL; AMIKACIN; AMPHOTERICIN; BUSULFAN; CEFAZOLIN; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; G NEUPOGEN; GANCICLOVIR; GENTAMICIN; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DR ANTIGEN; MEROPENEM; MEZLOCILLIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THYMOCYTE ANTIBODY; VANCOMYCIN;

ADOLESCENT; ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DONOR SELECTION; DRUG DOSE REGIMEN; DRUG TOLERABILITY; FANCONI ANEMIA; FEMALE; FEVER; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; MALE; MUCOSA INFLAMMATION; NEPHROTOXICITY; NEUTROPENIA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PNEUMOCYSTIS PNEUMONIA; SURVIVAL RATE; T CELL DEPLETION; TREATMENT OUTCOME; VEIN OCCLUSION;

ADULT; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTILYMPHOCYTE SERUM; BUSULFAN; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; FANCONI ANEMIA; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MYELOABLATIVE AGONISTS; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; VIDARABINE;

EID: 33745125737     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2006.03.002     Document Type: Article

References (30)

1. Alter B.P., and Young N.S. The bone marrow failure syndromes. In: Nathan D.G., and Orkin S.H. (Eds). Hematology of Infancy and Childhood (1998), Saunders, Philadelphia 237-335
2. Auerbach A.D., Buchwald M., and Joenje H. Fanconi anemia. In: Vogelstein B., and Kinzler K.W. (Eds). The Genetic Basis of Human Cancer. 2nd ed (2002), McGraw-Hill, New York 317-332
3. Joenje H., and Patel K.J. The emerging genetic and molecular basis of Fanconi anemia. Nat Rev Genet 2 (2001) 446-457
4. Giampletro P.F., Verlander P.C., Davis J.G., and Auerbach A.D. Diagnosis of Fanconi anemia in patients without congenital malformations. an International Fanconi Anemia Registry study. Am J Med Genet 68 (1997) 58-61
5. Strathdee C.A., Gavish H., Shannon W.R., and Buchwald M. Cloning of cDNA for Fanconi's anemia by functional complementation. Nature 356 (1992) 763-767
6. Howlett N., Toshiyasu T., Olson S., et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 297 (2002) 606-609
7. Gluckman E., Devergie A., Schaison G., et al. Bone marrow transplantation in Fanconi anaemia. Br J Haematol 45 (1980) 557-564
8. Berger R., Bernheim A., Gluckman E., and Gisselbrecht C. In vitro effect of cyclophosphamide metabolites on chromosomes of Fanconi anaemia patients. Br J Haematol 45 (1980) 565-568
9. Gluckman E., Auerbach A., Horowitz M., et al. Bone marrow transplantation for Fanconi anemia. Blood 86 (1995) 2856-2862
10. Socie G., Devergie A., Girinski T., et al. Transplantation for Fanconi's anemia. long-term follow-up of fifty patients transplanted from a sibling-donor after low-dose cyclophosphamide and thoraco-abdominal irradiation for conditioning. Br J Haematol 103 (1998) 249-255
11. Slavin S., Nagler A., Naparstek E., et al. Non-myeloablative transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and non-malignant hematologic diseases. Blood 91 (1998) 756-763
12. Champlin R., Khouri I., Kornblau S., et al. Reinventing bone marrow transplantation. Non-myeloablative preparative regimens and induction of graft-vs-malignancy effect. Oncology 13 (1999) 621-628
13. Kapelushnik J., Or R., Slavin S., and Nagler A. A fludarabine based protocol for bone marrow transplantation in Fanconi's anemia. Bone Marrow Transplant 20 (1997) 1109-1110
14. Kurre P., Pulsipher M., Woolfrey A., et al. Reduced toxicity and prompt engraftment after minimal conditioning of a patient with Fanconi anemia undergoing hematopoietic stem cell transplantation from an HLA-matched unrelated donor. J Pediatr Hematol Oncol 25 (2003) 581-583
15. Aker M., Varadi G., Slavin S., et al. Fludarabine-based protocol for human umbilical cord blood transplantation in children with Fanconi anemia. J Pediatr Hematol Oncol 21 (1999) 237-239
16. de Medeiros C.R., Silva L.M., and Pasquini R. Unrelated cord blood transplantation in a Fanconi anemia patient using fludarabine-based conditioning. Bone Marrow Transplant 28 (2001) 110-112
17. Boulad F., Gillio A., Small T.N., et al. Stem cell transplantation for the treatment of Fanconi anemia using a fludarabine-based cytoreductive regimen and T-cell-depleted related HLA-mismatched peripheral blood stem cell grafts. Br J Haematol 111 (2000) 1153-1157
18. Boyer M.W., Gross T.G., Loechelt B., Leemhuis T., Filipovich A., and Harris R.E. Low risk of graft-versus-host disease with transplantation of CD34 selected peripheral blood progenitor cells from alternative donors for Fanconi anemia. J Pediatr Hematol Oncol 25 (2003) 890-895
19. Rossi G., Giorgiani G., Comoli P., et al. Successful T-cell-depleted, related haploidentical peripheral blood stem cell transplantation in a patient with Fanconi anemia using a fludarabine-based preparative regimen without radiation. Bone Marrow Transplant 31 (2003) 437-440
20. Tan P.L., Wagner J.E., Auerbach A.D., Defor T.E., Slungaard A., and Macmillan M.L. Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation. Pediatr Blood Cancer 46 (2006) 630-636
21. Motwani J., Lawson S.E., and Darbyshire P.J. Successful HSCT using nonradiotherapy-based conditioning regimens and alternative donors in patients with Fanconi anaemia-experience in a single UK centre. Bone Marrow Transplant 36 (2005) 405-410
22. Glucksberg H., Storb R., Fefer A., et al. Clinical manifestations of graft-versus-host disease in human recipient of marrow from HLA-matched sibling donors. Transplantation 18 (1974) 295-304
23. Pugatsch T., Oppenheim A., and Slavin S. Improved single-step PCR assay for sex identification post-allogeneic sex-mismatched BMT. Bone Marrow Transplant 17 (1996) 273-275
24. Nakamura Y., Leppert O., O'Connel P., et al. Variable number of tandem repeats (VNTR) markets for human gene mapping. Science 235 (1987) 1616-1622
25. Gluckman E., Auerbach A.D., Horowitz M.M., et al. Bone marrow transplantation for Fanconi anemia. Blood 86 (1995) 2856-2862
26. Dufour C., Rondelly R., Locatelli F., et al. Stem cell transplantation from HLA-matched related donor for Fanconi's anemia. a retrospective review of the multicentric Italian experience on behalf of Associazione Italiana di ematologia ed oncologia pediatrica (AIEOP)-Gruppo Italiano trapianto di midollo osseo (GITMO). Br J Haematol 112 (2001) 796-805
27. Guardiola P., Pasquini R., Dokai I., et al. Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors. a study on behalf of the European Group for Blood and Marrow Transplantation. Blood 95 (2000) 422-429
28. Zanis-Neto J., Flowers M.E., Medeiros C.R., et al. Low-dose cyclophosphamide conditioning for haematopoietic cell transplantation from HLA-matched related donors in patients with Fanconi anaemia. Br J Haematol 130 (2005) 99-106
29. Guardiola P., Socie G., Li X., et al. Acute graft-versus-host disease in patients with Fanconi anemia or acquired aplastic anemia undergoing bone marrow transplantation from HLA-identical sibling donors. risk factors and influence on outcome. Blood 103 (2004) 73-77
30. Weiss L., and Slavin S. Prevention and treatment of graft vs host disease by down-regulation of anti-host reactivity with veto cells of host origin. Bone Marrow Transplant 23 (1999) 1139-1143